Antibiotics

The World Health Organization (WHO) has released their Global Tuberculosis Report for 2016, emphasizing that today’s global actions and investments are falling far short of what is needed to stop the worldwide tuberculosis (TB) epidemic.

Susan Kline, MD, MPH, associate professor of medicine, Division of Infectious Diseases and International Medicine, medical director for Infection Control, lead physician for Antibiotic Stewardship, University of Minnesota, discusses how restricting use of vancomycin impacted the emergence of vancomycin-resistant enterococci.

Rapid syphilis screening tests can be useful in community-based facilities, according to the results of five studies presented in a mini-plenary on September 22 at the Centers for Disease Control and Prevention 2016 STD Prevention Conference in Atlanta, Georgia.

Vikas Gupta, PharmD, BCPS, director of Clinical Strategy at Becton Dickinson, explains his team’s unique approach to understanding multidrug-resistant infections.

With new US Food and Drug Administration rules on antibiotics in agriculture taking effect at the start of 2017, challenges remain when it comes to the reduction of antimicrobial use in livestock.

Methicillin-resistant Staphylococcus aureus (MRSA) causes more than 11,000 deaths in the United States each year and a new study shows how this pathogen is able to evade last-line antibiotics.

The monoclonal antibody, ibalizumab, has proven to be both safe and effective in treating patients who are infected with multi-drug-resistant HIV-1 and have been previously treated.

At the ID Week meeting in New Orleans, Louisiana, a trio of speakers addressed some of the outpatient challenges regarding antimicrobial stewardship.

Susan Kline, MD, MPH, associate professor of medicine, Division of Infectious Diseases and International Medicine, medical director for Infection Control, lead physician for Antibiotic Stewardship, at the University of Minnesota, discusses the growing problem of antibiotic-resistance in hospital-acquired infections.

A trio of speakers addressed the global problem of antibiotic resistance and how the problem is especially vexing in Africa, Asia, and Latin America, at the annual conference of the Infectious Diseases Society of America in New Orleans, Louisiana.

Madeline King, PharmD, assistant professor of Clinical Pharmacy at the University of the Sciences, Philadelphia College of Pharmacy in Philadelphia, Pennsylvania, discusses ceftazidime-avibactam and its uses.

Doctors at the Children’s Hospital Colorado have published their research on a new approach to antibiotic stewardship, with promising reductions in antibiotic use and rates of Clostridium difficile.

Rita Olans, DNP, CPNP-PC, APRN-BC, assistant professor at MGH Institute of Health Professions, discusses the importance of incorporating staff nurses in a healthcare setting's antimicrobial stewardship program.

Vikas Gupta, PharmD, BCPS, director of Clinical Strategy at Becton Dickinson, discusses his research on the national prevalence of multidrug-resistant organisms.

Speakers at the Infectious Diseases Society of America annual conference plenary symposium in New Orleans, Louisiana, discuss past successes, current challenges, and future efforts regarding infectious disease.

Marcos Pires, PhD, assistant professor at Lehigh University, explains the inspiration behind his team’s research in immunotherapy as a new way to fight bacterial infection.

Researchers from Sweden’s Linköping University discover the pathway that leads to deadly infections in people co-infected with HIV and TB.

Marcos Pires, PhD, assistant professor at Lehigh University, explains the main points behind his research regarding immunotherapy.

While health officials continue to search for more novel tools to fight tuberculosis, a team of researchers has found that a class of antibiotics first introduced in the 1960s may offer an important weapon against the outbreaks of today.

In a recent study in mice, researchers used a synthetic peptide to disrupt the bacterial stress response that causes abscess formation in skin infections with drug-resistant bacteria.

Although they’re often life-saving, all hospital operations come with the risk of surgical site infections. C-section are no different, researchers, in a recent medical trial, have found a way to slash post-operative infection rates with the use of an extra antibiotic.

With the use of antibiotics remaining high and steady in American hospitals and healthcare facilities, new rules on infection prevention and antibiotic use are set to bring changes to thousands of nursing homes, nationwide.

The Centers for Disease Control and Prevention (CDC) has awarded scientists combating antibiotic resistance with more than $14 million in funding for new research and innovations by universities, nonprofits, and the business community.

Consumer Reports recently evaluated more than 3,100 hospitals in the United States and found that about a third of them received a low rating for controlling infections from Clostridium difficile.

Richard Krieger, MD, chairman of the Infection Control Committee at Chilton Medical Center, and infectious disease physician at ID care, explains how clinicians should manage patients with so-called “chronic Lyme disease.”

Following the recent United Nations General Assembly meeting to discuss the growing global threat of antimicrobial resistance, health experts are highlighting the role vaccines can play in preventing dangerous infections.

As antibiotic-resistant bacteria continue to endanger public health, greater attention from health officials and new US federal funding aimed at fighting superbugs, signal a new urgency in this battle.

Current traditional culture methods can take up to three days to identify bacteria and test antimicrobial resistances from a urine sample.